Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

"NIAID will evaluate and ADVANCE new drug candidates to the stage of being late Phase 2-ready. NIAID will manufacture products and conduct Phase I/II trials. NIAID aims to attract industry partners and shorten the time frame from scientific discovery to licensure to application of effective public health tools."

I think this is where we are striving to now (ADVANCE new drug candidates to the stage of being late Phase 2-ready). We could likely see a nasal prophylactic version of B ready to go soon.